Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03092934
Title A Study of AK-01 (LY3295668) in Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

lung small cell carcinoma

Her2-receptor negative breast cancer

Advanced Solid Tumor

Therapies

LY3295668

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.